These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 28365794)

  • 1. Response: Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Jul; 73(7):925. PubMed ID: 28365794
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of the effect of a gastrin/CCK
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.
    Boyce M; Dowen S; Turnbull G; van den Berg F; Zhao CM; Chen D; Black J
    Br J Clin Pharmacol; 2015 May; 79(5):744-55. PubMed ID: 25335860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical indications for a CCK
    Boyce M; Lloyd KA; Pritchard DM
    Curr Opin Pharmacol; 2016 Dec; 31():68-75. PubMed ID: 27710813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos induction.
    Hollestelle MJ; Timmerman P; Meloen RH; Höppener JW
    Endocr Relat Cancer; 2008 Mar; 15(1):301-9. PubMed ID: 18310296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer.
    Black JW
    Eur J Cancer; 2009 Feb; 45(3):360-4. PubMed ID: 19131241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer.
    Morton M; Prendergast C; Barrett TD
    Trends Pharmacol Sci; 2011 Apr; 32(4):201-5. PubMed ID: 21397342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: a gastrin antagonist against carcinoids--implications for PPI-induced hypergastrinaemia.
    McCarthy DM
    Aliment Pharmacol Ther; 2013 Jan; 37(2):276-7. PubMed ID: 23252778
    [No Abstract]   [Full Text] [Related]  

  • 9. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
    Sandvik AK; Waldum HL
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of capsaicin-sensitive afferent nerves and cholecystokinin 2/gastrin receptors in gastroprotection and adaptation of gastric mucosa to Helicobacter pylori-lipopolysaccharide.
    Brzozowski T; Konturek PC; Moran AP; Pajdo R; Kwiecien S; Konturek SJ; Sliwowski Z; Drozdowicz D; Pawlik WW; Hahn EG
    J Pharmacol Exp Ther; 2004 Jul; 310(1):116-25. PubMed ID: 15024038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of p38 MAPK in gastrin-induced u-PA expression in human colon cancer cells].
    Ming M; Yu JP; Zhou YH; Cao J; Song WC; Yu HG; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):4-8. PubMed ID: 17575684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dissection of the signaling pathways that control gastric acid secretion.
    Chen D; Friis-Hansen L; Håkanson R; Zhao CM
    Inflammopharmacology; 2005; 13(1-3):201-7. PubMed ID: 16259739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of gastric acid secretion - clinical perspectives.
    Waldum HL; Hauso Ø; Fossmark R
    Acta Physiol (Oxf); 2014 Feb; 210(2):239-56. PubMed ID: 24279703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical endocrinology and metabolism. Gastrin.
    Dockray GJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):555-68. PubMed ID: 15533775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin attenuates ischemia-reperfusion-induced intestinal injury in rats.
    Liu Z; Luo Y; Cheng Y; Zou D; Zeng A; Yang C; Xu J; Zhan H
    Exp Biol Med (Maywood); 2016 Apr; 241(8):873-81. PubMed ID: 26984262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of luminal gastrin in the regulation of pancreatic juice secretion in preruminant calves.
    Zabielski R; Normand V; Romé V; Woliński J; Chayvialle JA; Guilloteau P
    Regul Pept; 2004 Jul; 119(3):169-76. PubMed ID: 15120477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor.
    Slice LW; Hodikian R; Zhukova E
    J Cell Physiol; 2003 Sep; 196(3):454-63. PubMed ID: 12891702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
    Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
    Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells.
    Moore TC; Jepeal LI; Boylan MO; Singh SK; Boyd N; Beer DG; Chang AJ; Wolfe MM
    Regul Pept; 2004 Aug; 120(1-3):195-203. PubMed ID: 15177938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.
    Müerköster S; Isberner A; Arlt A; Witt M; Reimann B; Blaszczuk E; Werbing V; Fölsch UR; Schmitz F; Schäfer H
    Gastroenterology; 2005 Sep; 129(3):952-68. PubMed ID: 16143134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.